Trump says he’s open to a US-China trade deal

The Donald is open to an US-Chinese trade deal and has made it clear he’s willing to take it to the next level.

The Republican president told a meeting of Republican lawmakers in Virginia on Wednesday that he’d be open to negotiating a deal with China, the Guardian newspaper reported.

The statement came as the administration and Beijing prepare to unveil a sweeping new economic and security pact between the world’s two biggest economies.

Trump has repeatedly called for a trade deal with Beijing, which is struggling to contain a deadly pandemic that has claimed more than 100,000 lives.

The new pact will be the first of its kind, Trump told lawmakers, calling it the “gold standard” of free trade and the “single most important thing that we can do.”

China and the US have been at odds for years over the North Korean crisis, which has seen the two nations ratchet up tensions and threatened to escalate tensions on the Korean peninsula.

The White House is expected to announce the deal on Thursday.

Trump also promised to give Congress a tax cut next year and that he would appoint a new director of the US Trade Representative.

How the World’s Most Expensive Drug War Became the Most Expensive

The World Health Organization’s (WHO) annual report for 2017 is the latest salvo in its battle against the drug industry.

The World Trade Organization (WTO) had approved more than 1.5 million pharmaceuticals, the most since the 1970s, and the UN’s World Health Assembly (WHOHAS) had unanimously approved 1.3 million, the highest number since 1992.

This is despite the fact that the WHO’s report, released last week, revealed a record number of deaths and serious medical conditions due to prescription opioids worldwide.

The WHO’s most recent data, from 2017, also found that nearly 4 million people died of prescription drug overdoses in the United States alone.

However, it is the pharmaceutical industry’s lobbying prowess that is driving the push for more drug war policies, particularly in Europe.

The pharmaceutical industry, which is pushing for the U.S. to lift its ban on exports of its opioids, is hoping to pressure the European Union (EU) to allow imports of its painkillers.

The EU, which has an estimated $20 trillion in annual sales, has long been a leading advocate of the drug war, and now it has a new ally in its fight against the opioid crisis.

The drug industry has lobbied hard for the passage of the opioid legislation in the European Parliament, which passed the bill in June.

The lobbying group for the pharmaceuticals industry, the European Commission, has been actively lobbying European countries to allow their citizens to obtain drugs from the United Kingdom.

It has also pushed for increased access to prescription drugs in the U